IRIS
COLAGROSSI, LUNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.682
EU - Europa 244
AS - Asia 175
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.682
SG - Singapore 99
IT - Italia 86
IE - Irlanda 59
KR - Corea 49
DE - Germania 21
CN - Cina 20
RU - Federazione Russa 20
GB - Regno Unito 11
CZ - Repubblica Ceca 9
FR - Francia 9
SE - Svezia 8
UA - Ucraina 8
FI - Finlandia 5
IN - India 5
AU - Australia 3
BE - Belgio 3
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
NL - Olanda 1
PL - Polonia 1
TR - Turchia 1
VN - Vietnam 1
Totale 2.107
Salva come PNG Salva come JPEG
Città #
Wilmington 486
Houston 345
Woodbridge 132
Fairfield 111
Chandler 102
Singapore 89
Dublin 44
Ashburn 41
Seattle 38
Rome 36
New York 32
Ann Arbor 29
Cambridge 29
Santa Clara 29
Medford 26
Dearborn 18
Beijing 14
Munich 14
Lawrence 12
Milan 12
Engelhard 10
Menlo Park 10
San Diego 8
San Jose 7
Creede 6
St. George 6
Cedarhurst 5
Colorado Springs 5
Council Bluffs 5
Helsinki 5
Nepi 5
Olomouc 5
Brno 4
London 4
Los Angeles 4
The Dalles 4
Brussels 3
Kilburn 3
Moscow 3
Palazzolo sull'Oglio 3
Palo Alto 3
Albano Laziale 2
Bari 2
Bengaluru 2
Bollate 2
Durham 2
Jacksonville 2
Pune 2
Roebling 2
San Francisco 2
Seoul 2
Athens 1
Belgrade 1
Canberra 1
Clearwater 1
Geislingen an der Steige 1
Guangzhou 1
Hefei 1
Hounslow 1
Kraków 1
Leawood 1
Madrid 1
Melbourne 1
Mountain View 1
Mülheim 1
Nanchang 1
Nanjing 1
North Hollywood 1
Prineville 1
Saint Petersburg 1
San Severo 1
Sydney 1
São Paulo 1
Torre del Greco 1
Totale 1.790
Salva come PNG Salva come JPEG
Nome #
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 397
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 327
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 287
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe 219
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 174
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 172
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 110
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 61
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 54
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B 47
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 47
An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression 43
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 39
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 34
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 33
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 33
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 32
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 28
Influenza viruses circulation in a tertiary care children hospital in Rome: a comparison between 2022 and the previous 5 years 14
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence 12
Humoral and cellular immunogenicity and safety up to 4 months after vaccination with BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults 12
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis 8
Whooping Cough Cases Increase in Central Italy after COVID-19 Pandemic 4
Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy 3
Totale 2.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 0 0 0 46 66 54 45 72 43 40 40
2020/2021341 34 30 39 36 30 42 61 39 7 9 7 7
2021/2022168 1 8 0 7 20 6 11 1 61 12 6 35
2022/2023330 20 28 25 21 42 49 42 29 31 9 28 6
2023/2024147 12 21 13 5 19 28 15 4 2 11 1 16
2024/2025245 17 111 69 37 11 0 0 0 0 0 0 0
Totale 2.190